Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa

被引:18
|
作者
Cheng, Chih-Yuan [1 ,2 ,3 ]
Quaife, Matthew [1 ]
Eakle, Robyn [4 ]
Escobar, Maria A. Cabrera [4 ]
Vickerman, Peter [5 ]
Terris-Prestholt, Fern [1 ]
机构
[1] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England
[2] Heidelberg Univ, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany
[3] German Canc Res Ctr, Div Hlth Econ, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[4] Univ Witwatersrand, Wits RHI, 22 Esselen St, ZA-2001 Johannesburg, South Africa
[5] Univ Bristol, Sch Social & Community Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England
基金
英国经济与社会研究理事会;
关键词
HIV prevention; Long-acting injectable pre-exposure prophylaxis; Heterosexual men; South Africa; Biomedical strategies; ANTIRETROVIRAL PROPHYLAXIS; PREVENTION; INFECTION; SEX; RISK; PREFERENCES; TRANSMISSION; WILLINGNESS; PERCEPTIONS; TENOFOVIR;
D O I
10.1186/s12889-019-7276-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundHeterosexual men in South Africa are a large key population to exposure to HIV, yet preferences for HIV pre-exposure prophylaxis (PrEP) among this population have not, to date, been investigated in the literature. This paper aims to explore HIV prevention preferences among heterosexual men in urban South Africa, as well as to examine the demand and characteristics of men who favour long-acting injectable (LAI) PrEP over condoms and oral PrEP.MethodsData were collected among 178 self-reported HIV-negative heterosexual men, who were given example products and information before being asked which they preferred. Multivariate logistic regression was used to analyse which characteristics were associated with product choice.Results48% (n=85) of participants preferred LAI PrEP, while 33% (n=58) and 20% (n=35) chose oral PrEP and condoms respectively. Having children (marginal effect=0.22; 95% CI [0.01, 0.44]) or having higher risk attitude scores (marginal effect=0.03; 95% CI [0.01, 0.06]) was significantly associated with a choice of LAI PrEP, while those who had unprotected anal intercourse (marginal effect=-0.42; 95% CI [-0.57, -0.27]) and those who were concerned with protection against other sexually transmitted infections over HIV (marginal effect=-0.42; 95% CI [-0.60, -0.24]) appeared less likely to prefer LAI PrEP.ConclusionsThe results suggested a relatively high demand and theoretical acceptability for LAI PrEP among heterosexual men in urban South Africa, but there appeared to be fewer distinct predictors for the willingness to use LAI PrEP compared to studies conducted among gay and bisexual men and women. Nevertheless, the findings contribute to the mapping of the demand and determinants of heterosexual men's preferences for novel antiretroviral-based prevention in sub-Saharan Africa, and the data could aid in the differentiated design of future HIV prevention strategies using LAI PrEP in conjunction with other methods.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Ethical issues in establishing the efficacy and safety of long-acting injectable pre-exposure prophylaxis for HIV prevention: the HPTN 083 trial
    Sugarman, Jeremy
    Donnell, Deborah J.
    Hanscom, Brett
    McCauley, Marybeth
    Grinsztejn, Beatriz
    Landovitz, Raphael J.
    LANCET HIV, 2021, 8 (11): : E723 - E728
  • [42] Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university
    Atuhaire, Bridget
    Muteebwa, Laban
    Nabunya, Racheal
    Muhindo, Richard
    Ngabirano, Tom Denis
    Osingada, Charles Peter
    Muwanguzi, Patience A.
    AIDS RESEARCH AND THERAPY, 2024, 21 (01):
  • [43] Transgender Women’s Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)
    Christine Tagliaferri Rael
    Javier Lopez-Ríos
    Stacey A. McKenna
    Doyel Das
    Curtis Dolezal
    Elena Abascal
    Alex Carballo-Diéguez
    Rebecca Schnall
    Thomas J. Hope
    José Bauermeister
    Walter Bockting
    AIDS and Behavior, 2021, 25 : 4180 - 4192
  • [44] Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP)
    Rael, Christine Tagliaferri
    Lopez-Rios, Javier
    McKenna, Stacey A.
    Das, Doyel
    Dolezal, Curtis
    Abascal, Elena
    Carballo-Dieguez, Alex
    Schnall, Rebecca
    Hope, Thomas J.
    Bauermeister, Jose
    Bockting, Walter
    AIDS AND BEHAVIOR, 2021, 25 (12) : 4180 - 4192
  • [45] Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs
    Shrestha, Roman
    DiDomizio, Elizabeth E.
    Kim, Rayne S.
    Altice, Frederick L.
    Wickersham, Jeffrey A.
    Copenhaver, Michael M.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 117
  • [46] Variation in Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among US Men Who Have Sex with Men: A Latent Class Analysis
    Beckham, S. Wilson
    Sanchez, Travis
    Fowler, Rebecca
    Zlotorzynska, Maria
    Rai, Mona
    Sullivan, Patrick
    Vannappagari, Vani
    Sarkar, Supriya
    Glick, Jennifer L.
    Rinehart, Alex R.
    Rawlings, Keith
    Bridges, John F. P.
    AIDS PATIENT CARE AND STDS, 2023, 37 (10) : 495 - 503
  • [47] Acceptability, adherence, preference and safety of placebo long-acting pre-exposure prophylaxis (LA-PrEP) injections and implants for HIV-prevention in South African men: the SAMURAI study
    Montgomery, E.
    Palanee-Phillips, T.
    Atujuna, M.
    Hart, C.
    Reddy, K.
    Gill, K.
    Michaels, J.
    Bekker, L. G.
    Ndlovu, N.
    MacDonald, P.
    Chappell, C.
    Zulu, S.
    Nomvuyo, M.
    Mbochi, G.
    Minnis, A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27
  • [48] Preferences and willingness for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among transfeminine persons in the US, 2022-2023
    Islek, Duygu
    Sanchez, Travis
    Baral, Stefan
    Brown, Carolyn
    Caldwell, Joanna A.
    Glick, Jennifer L.
    Nestadt, Danielle Friedman
    Jones, Jeb
    Lucas, Iaah L.
    Sarkar, Supriya
    de Ruiter, Annemiek
    Sullivan, Patrick S.
    Valentine-Graves, Mariah
    Winter, Savannah
    Vannappagari, Vani
    PLOS ONE, 2025, 20 (04):
  • [49] Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa
    Ogunbajo, Adedotun
    Tsai, Alexander C.
    Kanki, Phyllis J.
    Mayer, Kenneth H.
    AIDS AND BEHAVIOR, 2022, 26 (07) : 2363 - 2375
  • [50] Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa
    Adedotun Ogunbajo
    Alexander C. Tsai
    Phyllis J. Kanki
    Kenneth H. Mayer
    AIDS and Behavior, 2022, 26 : 2363 - 2375